Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2013
08/21/2013CN102229588B Briarane type diterpenoid compounds with anti-tumor and antibacterial activities and application thereof
08/21/2013CN102216302B Akt and p70 s6 kinase inhibitors
08/21/2013CN102210725B Application of hypericum japonicum thunb general flavone in preparing medicament for treating hepatic fibrosis
08/21/2013CN102210684B Application of ectoine and derivants thereof in preparation of medicament for treating cataract
08/21/2013CN102204891B Pharmaceutical formulation comprising a pyrimidine-A-one derivative coated with an enteric polymer
08/21/2013CN102198148B Compound malic acid Ringer's solution and application thereof
08/21/2013CN102198139B Pharmaceutical composition with antineoplastic effect, and application method thereof
08/21/2013CN102183665B Method and apparatus for monitoring anti-platelet agents
08/21/2013CN102138899B Olmesartan liposome solid preparation
08/21/2013CN102133199B Doxofylline lyophilized preparation for injection and preparation method thereof
08/21/2013CN102127056B Tubulin inhibitors
08/21/2013CN102125534B Pantoprazole sodium enteric-coated capsule and preparation method thereof
08/21/2013CN102099337B Piperazine derivatives used as cav2.2 calcium channel modulators
08/21/2013CN102091083B Petroleum ether extract of traditional Chinese medicine for preventing and treating glucose and lipid metabolic disturbance and preparation method thereof
08/21/2013CN102091041B Novel nanoparticle of camptothecin drug and preparation method thereof
08/21/2013CN102088982B Preparation of intermediates useful in the syntheis of 2'-cyano-2'-deoxy-N4-palmitoyl-1-beta-D-arabinofuranosylcytosine
08/21/2013CN102088975B Pharmaceutical compositions based on kinin B2 receptor antagonists and corticosteroids, and their use
08/21/2013CN102085378B Application of hfgl2 (Human Fibrinogen-like protein 2) inhibitor in preparation of medicaments for treating liver cancer
08/21/2013CN102070618B Compound and crystals thereof
08/21/2013CN102068446B Application of triterpenoid saponin compound in preparation of anti-pathogeny microorganism medicament
08/21/2013CN102066359B Novel heteroaryl carboxamide derivatives
08/21/2013CN102050772B Bimatoprost crystal as well as preparation method and purposes thereof
08/21/2013CN102036963B Derivatives of quinolines and quinoxalines as protein tyrosine kinase inhibitors
08/21/2013CN102030800B Abies holophylla triterpenoid compound, extraction separation thereof and application thereof
08/21/2013CN102018646B Skin-care composition and skin-care preparation with acne-removing effect and preparation method thereof
08/21/2013CN101981015B 3-trifluoromethyl-pyrazine-2-carboxylic acid amide derivatives as HDL-cholesterol raising agents
08/21/2013CN101952296B Pyrrolopyrazine kinase inhibitors
08/21/2013CN101941970B Meleimide derivatives, pharmaceutical compositions and methods for treatment of cancer
08/21/2013CN101928226B N-(2-ethoxy) feriilamidoethyl nitrate compound and preparation method thereof
08/21/2013CN101925451B Method for coating silicone hydrogels
08/21/2013CN101917993B Compounds for use in the treatment of cancer
08/21/2013CN101917983B Composition for treating sterile inflammation
08/21/2013CN101910143B Condensed aminodihydrothiazine derivative
08/21/2013CN101899010B Quinazol derivative, preparation method and application thereof
08/21/2013CN101884629B Controlled release preparation
08/21/2013CN101883569B Synthesis of oseltamivir containing phosphonate congeners with anti-influenza activity
08/21/2013CN101861316B Imidazo[1,2-a]pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors
08/21/2013CN101856363B Application of Bortezomib in preparing drugs for curing POEMS syndrome
08/21/2013CN101854815B Powder composition
08/21/2013CN101848892B Hydrobenzamide derivatives as inhibitors of HSP90
08/21/2013CN101817799B Cyanoacrylate compound and application thereof in pesticide and medicine
08/21/2013CN101815519B Pharmaceutical compositions containing dopamine receptor ligands and methods of treatment using dopamine recptor ligands
08/21/2013CN101790517B Inhibitor of binding of s1p1
08/21/2013CN101784533B 4-benzylaminoquinolines, pharmaceutical compositions containing them, and their use in therapy
08/21/2013CN101766723B Chinese medicine preparation for treating traumatic injury and rheumatic pain and preparation method thereof
08/21/2013CN101766549B Combination of monosaccharides and desquamating agents, and use thereof
08/21/2013CN101754774B Synergistic combinations of VR-1 antagonists and COX-2 inhibitors
08/21/2013CN101743244B Substituted (oxazolidinon-5-yl-methyl) -2-thiophene-carboxamides and use thereof in the field of blood coagulation
08/21/2013CN101742996B Use of phorbol in preparing medicine for non-cancer skin lesions
08/21/2013CN101723933B Piperidine-4-ketone-O-substituted oxime triadimenol-type antifungal compound and preparation method thereof
08/21/2013CN101721467B Method for preparing total salvianolic acid
08/21/2013CN101696159B Method for extracting and separating eugenol, pharmaceutical composition containing eugenol and preparation method thereof
08/21/2013CN101663030B Composition useful for the prevention of type 2 diabetes and its complications in pre-diabetic patients with insulin resistance
08/21/2013CN101631785B Substituted dihydropyrazolones for treating cardiovascular and haematological diseases
08/21/2013CN101626768B Synthesis, methods of using, and compositions of cycloalkylmethylamines
08/21/2013CN101607904B Propanoic acid derivatives and synthesis method and application thereof
08/21/2013CN101600714B Novel pyrindole kinase inhibitors
08/21/2013CN101600700B Novel 2-aminooxazolines as taar1 ligands for CNS disorders
08/21/2013CN101600346B Tannate salt of rasagiline
08/21/2013CN101591322B Cyclin dependent kinases inhibitor scutellaria flavonoid organic amine derivatives, preparation method and application thereof
08/21/2013CN101583363B Method of treating or preventing infertility in a female mammal and pharmaceutical kit for use in such method
08/21/2013CN101583286B Liquid formulations containing carotenoid
08/21/2013CN101573382B Monoclonal antibodies and directed against the human anti-mullerian hormone type ii receptor (amhr-ii)
08/21/2013CN101558078B Macrolide compounds endowed with antiinflammatory activity
08/21/2013CN101547915B Piperidinylamino-pyridazines and their use as fast dissociating dopamine 2 receptor antagonists
08/21/2013CN101544592B Process for preparation of N-arylsulfonyl-3-substituted indoles
08/21/2013CN101500654B Compositions for the treatment of chronic degenerative inflammatory conditions
08/21/2013CN101500572B Solid compositions comprising tadalafil and at least one carrier
08/21/2013CN101484410B Terphenyl derivatives for treatment of alzheimer's disease
08/21/2013CN101479238B Amine derivative having npyy5 receptor antagonist activity
08/21/2013CN101478966B Compressed preparation
08/21/2013CN101472891B Crystalline forms of 4- [2- (4-methylphenylsulfanyl) -phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain
08/21/2013CN101439066B Chinese medicine granular containing notoginseng extract and preparation method thereof
08/21/2013CN101429166B Quinazoline ketone derivant, preparation method and application thereof
08/21/2013CN101421258B Sulfonyl-substituted bicyclic compounds as modulators of ppar
08/21/2013CN101415710B Bicyclic imidazole or thiadiazole heterocycles useful as selective androgen receptor modulators
08/21/2013CN101389604B Beta-crystalline form of perindopril arginine salt, method for making same, and pharmaceutical compositions containing same
08/21/2013CN101389323B Pharmaceutical composition comprising oseltamivir phosphate
08/21/2013CN101300004B Methods for treating viral infections using polyamine analogs
08/21/2013CN101273028B Macrocyclic inhibitors of hepatitis C virus
08/21/2013CN101203500B Substituted arylamine compounds and uses as 5-HT6 moderator thereof
08/21/2013CN101193862B Hydroxybenzamide derivatives and their use as inhibitors of HSP90
08/21/2013CN101050194B Derivative of bicyclo-octanes class, preparation method, and application of medicine
08/21/2013CN101019024B Taxol immunoassay method
08/21/2013CN101007195B Reperfusion protection in resuscitation
08/20/2013US8513433 Small molecule inhibitors of PARP activity
08/20/2013US8513432 Dual-acting benzoimidazole antihypertensive agents
08/20/2013US8513430 Substituted thiazol-2-ylamine derivatives, pharmaceutical compositions, and methods of use as 11-beta HSD1 modulators
08/20/2013US8513428 Process for preparing atazanavir bisulfate and novel forms
08/20/2013US8513425 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives and uses thereof
08/20/2013US8513424 Pyridone GPR119 G protein-coupled receptor agonists
08/20/2013US8513423 Piperidin-4-yl-azetidine diamides as monoacylglycerol lipase inhibitors
08/20/2013US8513422 Piperidine derivative
08/20/2013US8513420 Amino-naphthyridine derivatives
08/20/2013US8513406 Pharmaceutical compositions comprising forms of 5-azacytidine
08/20/2013US8513310 Cosmetic use of phytosphingosine as slimming agent and cosmetic compositions comprising phytosphingosine
08/20/2013US8513309 Perfluorocarbons for use in treating pruritus
08/20/2013US8513308 PAK1 agonists and methods of use
08/20/2013US8513307 N-phenylacetamide inhibitors of the enzyme SOAT-1 and pharmaceutical/cosmetic compositions comprised thereof
08/20/2013US8513303 Antimicrobial agent
1 ... 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 ... 7860